Antigenicity, Immunotoxicology and Immunogenicity
• Extensive experience and expertise in immune system evaluation enabling sponsors to rapidly assess the impact of possible immunological adverse effects in a variety of different species
• Bioanalytical laboratories use state-of-the-art immunogenicity technology to detect if antibodies are generated to biosimilars, and determine if the antibodies are neutralizing
• Multiple technologies used to screen the appearance of antibodies
• Ability to analyze 15,000 samples per month – speed
• GLP-certified by Swissmedic for preclinical and clinical sample analysis, and also accepted by all regulatory bodies throughout the OECD
Return to the overview.